成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

PEP2-EVKI

PEP2-EVKI Struktur
1315378-67-6
CAS-Nr.
1315378-67-6
Englisch Name:
PEP2-EVKI
Synonyma:
PEP2-EVKI;L-Isoleucine, L-tyrosyl-L-asparaginyl-L-valyl-L-tyrosylglycyl-L-isoleucyl-L-α-glutamyl-L-α-glutamyl-L-valyl-L-lysyl-
CBNumber:
CB8489180
Summenformel:
C62H95N13O19
Molgewicht:
1326.51
MOL-Datei:
1315378-67-6.mol

PEP2-EVKI Eigenschaften

Siedepunkt:
1706.2±65.0 °C(Predicted)
Dichte
1.289±0.06 g/cm3(Predicted)
storage temp. 
Desiccate at -20°C
L?slichkeit
Soluble to 1 mg/ml in PBS (pH6.8)
Aggregatzustand
Powder
pka
3.38±0.10(Predicted)

Sicherheit

PEP2-EVKI Chemische Eigenschaften,Einsatz,Produktion Methoden

PEP2-EVKI Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

PEP2-EVKI Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 22)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shenzhen Nexconn Pharmatechs Ltd 		+86-755-89396905 +86-15013857715
 admin@nexconn.com China 10311 58
BOC Sciences 		16314854226; +16314854226
 inquiry@bocsci.com United States 19741 58
Zhejiang Hangyu API Co., Ltd 		+8617531972939
 anna@api-made.com China 2943 58
Changsha MOL Changes Biotechnology Co., Ltd. 		+8619375158599
 info@molchanges.com China 5223 58
3B Pharmachem (Wuhan) International Co.,Ltd. 821-50328103-801 18930552037
 3bsc@sina.com China 15839 69
GL Biochem (Shanghai) Ltd 21-61263452 13641803416
 ymbetter@glbiochem.com China 9981 64
Creative Peptides
info@creative-peptides.com United States 6083 56
Chengdu Youngshe Chemical Co., Ltd. +86-17380623303 +86-17380623303
 Caroline@youngshechem.com China 4809 58
Hangzhou Peptidego Biotech Co.,Ltd. 0571-87213919
Eric@peptidego.com China 6941 58
Nanjing Meihao Pharmaceutical Technology Co., Ltd. meitaochem@126.com
meitaochem@126.com China 19103 58
  • PEP2-EVKI
  • L-Isoleucine, L-tyrosyl-L-asparaginyl-L-valyl-L-tyrosylglycyl-L-isoleucyl-L-α-glutamyl-L-α-glutamyl-L-valyl-L-lysyl-
  • 1315378-67-6
  • C62H95N13O19
  • Glutamate receptor
Copyright 2019 ? ChemicalBook. All rights reserved